RankingsPricing
  1. US-listed companies
  2. NEUROCRINE BIOSCIENCES INC
  3. Financials
  4. Return on equity (%)

NEUROCRINE BIOSCIENCES INCNBIX

Market cap
$15.3B
P/E ratio
SummaryFinancials
Period EndReturn on equity (%) (Million USD)YoY (%)
Dec 31, 202414.2+11.67%
Dec 31, 202312.7+26.42%
Dec 31, 202210+39.89%
Dec 31, 20217.2-84.48%
Dec 31, 202046.2+597.89%
Dec 31, 20196.6+33.74%
Dec 31, 20185-111.93%
Dec 31, 2017-41.5+8.72%
Dec 31, 2016-38.2+35.88%
Dec 31, 2015-28.1-23.65%
Dec 31, 2014-36.8+9.66%
Dec 31, 2013-33.5-815.35%
Dec 31, 20124.7

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)